Oncology and Hematology News and Journal Articles
Phillip L. Palmbos, MD, PhD, and Maha H. Hussain, MD
This article will review how PARP inhibitors function as a class, review the molecular features that sensitize cancer cells to this therapy, and discuss the data supporting its potential for patients with prostate cancer.
A new study has identified several trends by race and ethnicity among patients with hepatocellular carcinoma (HCC) in the United States.
The accuracy of interpreting a breast cancer screening mammogram is not diminished when clinicians evaluate more mammograms in a single session.
A 5-year analysis of the DASISION trial showed that dasatinib continued to offer better responses than imatinib in patients with chronic myeloid leukemia.
Gonadotropin-releasing hormone agonist (GnRHa) did not prevent chemotherapy-induced premature ovarian failure in young women with lymphoma.
Women who do not engage in regular physical activity have an increased risk of developing cervical cancer, according to a new study
Grade 3/4 neutropenia is a common adverse event experienced by patients undergoing treatment for relapsed, refractory multiple myeloma with lenalidomide and dexamethasone, a new study has found.
In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara examines a recent report that warns of different factors associated with an increased risk of stomach cancer.
In this video, Dr. Paz-Ares discusses a phase III study that showed that nivolumab improved survival and response rates in previously treated patients with metastatic non-squamous non-small-cell lung cancer (NSCLC).
In this video, Steven I. Sherman, MD, discusses the final overall survival analysis of the EXAM study, a randomized, placebo-controlled phase III trial of cabozantinib in medullary thyroid carcinoma patients.
In this video, Dr. El-Khoueiry discusses results from a phase I/II study that suggest the PD-1 inhibitor nivolumab is safe and effective in advanced hepatocellular carcinoma.
The journal ONCOLOGY includes a cartoon at the end of each issue. Here are the collected cartoons to date.